Other
Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
Abstract
Acute decompensated heart failure accounts for more than 1 million hospitalizations in the United States annually. Whether the initiation of sacubitril–valsartan therapy is safe and effective among patients who are hospitalized for acute decompensated heart failure is...
Paper Details
Title
Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
Published Date
Feb 7, 2019
Volume
380
Issue
6
Pages
539 - 548
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History